✦ LIBER ✦

The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia

✍ Scribed by Iriyama, Noriyoshi; Hatta, Yoshihiro; Kobayashi, Sumiko; Uchino, Yoshihito; Miura, Katsuhiro; Kurita, Daisuke; Kodaira, Hitomi; Inoue, Mitsuru; Takei, Masami

Book ID: 125833865
Publisher: Carden Jennings Publishing
Year: 2014
Tongue: English
Weight: 404 KB
Volume: 100
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-014-1649-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of suboptimal response to i

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase

✍ Yesid Alvarado; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Gautam Borthakur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 2 views

## Abstract ## BACKGROUND: The European LeukemiaNet recommendations for chronic myeloid leukemia (CML) defined a group of patients with suboptimal response to imatinib. The significance of this response was not well defined. ## METHODS: The significance of having had a suboptimal response during